Data on AstraZeneca vaccine insufficient for Swiss approval - SWI swissinfo.ch
Swiss medical regulator rejects Oxford/AstraZeneca Covid vaccine | Financial Times
Covid certificate not as simple as it seems for Swiss abroad - SWI swissinfo.ch
Side effects of COVID-19 vaccines in Switzerland – update
Swiss delay AstraZeneca COVID vaccine approval, order more shots from others | Reuters
Covid-19 - Prix de Lausanne
COVID-19 Information
Side effects of COVID-19 vaccines in Switzerland – update
COVID vaccine: EMA approves new production sites in Germany, Netherlands, Switzerland | News | DW | 26.03.2021
Switzerland okays its first vaccine against COVID-19
Swiss Medical Weekly - Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic – a pilot study
Switzerland to ban non-EU vaccine certificates for events | Business Travel News Europe
Swiss secure three million more vaccine doses
Side effects, myths & questions on vaccination | FOPH
AstraZeneca COVID-19 Vaccine Data 'Not Sufficient' For Approval In Switzerland :: Pink Sheet
Swiss Global Health (@BAG_INT) / Twitter
Vaccination
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
Entering Switzerland
Side effects of COVID-19 vaccines in Switzerland – update
Swiss delay AstraZeneca COVID vaccine approval, order more shots from others | Reuters
Swiss regulator seeks more data on AstraZeneca vaccine
Insufficient data': Switzerland declines to approve AstraZeneca vaccine
Entering Switzerland
Swiss sign next vaccine agreement with AstraZeneca - SWI swissinfo.ch
Covid-19
Switzerland withholds approval for AstraZeneca Covid vaccine citing lack of evidence | The Independent
First Covid-19 vaccine approved for Swiss use - SWI swissinfo.ch
